We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Approves Revised Label for Boehringer’s Catapres
FDA Approves Revised Label for Boehringer’s Catapres
April 16, 2010
The FDA has approved Boehringer Ingelheim’s revised labeling for its hypertension drug Catapres to include new information on heart-rate monitoring.